Stockscreener 앱 받기
3.90
2.50%
-0.10
시간 외 거래:
3.81
-0.09
-2.31%
전일 마감가:
$4.00
열려 있는:
$4
하루 거래량:
315.69K
Relative Volume:
1.94
시가총액:
$184.07M
수익:
$7.15M
순이익/손실:
$-20.60M
주가수익비율:
8.2174
EPS:
0.4746
순현금흐름:
$-97.99M
1주 성능:
+14.37%
1개월 성능:
-0.26%
6개월 성능:
+85.71%
1년 성능:
+132.14%
1일 변동 폭
$3.74
$4.10
1주일 범위
$3.32
$4.10
52주 변동 폭
$1.39
$4.4799
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
명칭
Whitehawk Therapeutics Inc
전화
551-321-2234
주소
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
3.90 | 188.79M | 7.15M | -20.60M | -97.99M | 0.4746 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-05 | 개시 | Oppenheimer | Outperform |
| 2024-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | 개시 | Jefferies | Buy |
| 2021-10-01 | 개시 | Cowen | Outperform |
| 2021-09-14 | 개시 | Ladenburg Thalmann | Buy |
| 2021-09-08 | 개시 | Piper Sandler | Overweight |
모두보기
Whitehawk Therapeutics Inc 주식(WHWK)의 최신 뉴스
Whitehawk Therapeutics officer Ball sells $427,860 in stock By Investing.com - Investing.com Canada
Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks - Yahoo Finance
Whitehawk Therapeutics officer Ball sells $201k in stock - Investing.com
Whitehawk Therapeutics officer Ball sells $201k in stock By Investing.com - Investing.com India
Whitehawk Therapeutics (WHWK) insider disposes 56,596 shares for tax withholding - Stock Titan
EV Market: Will Whitehawk Therapeutics Inc benefit from government policyWeekly Stock Report & Free Community Supported Trade Ideas - baoquankhu1.vn
Whitehawk Therapeutics (WHWK) price target increased by 13.33% to 5.78 - MSN
Trade Alert: President Of Whitehawk Therapeutics David Lennon Has Sold Stock - simplywall.st
Whitehawk Therapeutics CEO Lennon sells $49k in shares By Investing.com - Investing.com Australia
Whitehawk Therapeutics CEO Lennon sells $49k in shares - Investing.com
Whitehawk Therapeutics (WHWK) CEO sells 14,500 shares for taxes - Stock Titan
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 - PR Newswire
WHWK Stock Price, Quote & Chart | WHITEHAWK THERAPEUTICS INC (NASDAQ:WHWK) - ChartMill
Rally Mode: Can Whitehawk Therapeutics Inc sustain its profitability2026 Big Picture & Real-Time Buy Signal Alerts - baoquankhu1.vn
WHWK insider files Form 144 to sell 366,532 RSUs (NASDAQ: WHWK) - Stock Titan
Insider sales reported for WhiteHawk Therapeutics (NASDAQ: WHWK) during March–April 2026 - Stock Titan
Travel Stocks: Does Whitehawk Therapeutics Inc have a sustainable dividend2026 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Whitehawk (WHWK) CEO disposes 260K shares to satisfy tax obligations - Stock Titan
Whitehawk Therapeutics CEO Lennon sells $899k in shares By Investing.com - Investing.com Canada
WHWK | Whitehawk Therapeutics, Inc. Common FinancialsIncome Statement - Quiver Quantitative
Market Wrap: How does Whitehawk Therapeutics Inc score in quality rankings2026 Biggest Moves & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Recap: Does Whitehawk Therapeutics Inc have a sustainable dividendQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn
Whitehawk therapeutics CEO Lennon sells $93k in shares By Investing.com - Investing.com South Africa
Whitehawk therapeutics CEO Lennon sells $93k in shares - investing.com
WHWK: Whitehawk Therapeutics, Inc.Comparative Chart - Zacks Investment Research
Whitehawk Therapeutics (WHWK) lists 775,828 RSUs; recent 5,100-share sale - Stock Titan
Gap Down: Will Whitehawk Therapeutics Inc outperform the market in YEAR2026 Levels & Risk Controlled Swing Alerts - baoquankhu1.vn
Portfolio Update: Does Whitehawk Therapeutics Inc have a sustainable dividendWall Street Watch & Safe Entry Trade Signal Reports - baoquankhu1.vn
Whitehawk’s First-in-Human PTK7 ADC Trial Moves Ahead: What Investors Should Know - TipRanks
Nasdaq Moves: Can Whitehawk Therapeutics Inc reach resistance levels soon2026 Buyback Activity & Risk Controlled Daily Plans - baoquankhu1.vn
Aug Selloffs: Can Whitehawk Therapeutics Inc reach resistance levels soon2026 Intraday Action & Technical Buy Zone Confirmation - baoquankhu1.vn
Bank Watch: What are Whitehawk Therapeutics Incs earnings expectationsVolume Spike & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Meme Stocks: Will Whitehawk Therapeutics Inc benefit from government policyWeekly Trading Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Wall Street Zen Upgrades Whitehawk Therapeutics (NASDAQ:WHWK) to Hold - MarketBeat
Whitehawk Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 3350 | US00032Q1040 - marketscreener.com
Aug Technicals: Can Whitehawk Therapeutics Inc sustain its profitability2026 Biggest Moves & Entry Point Confirmation Signals - baoquankhu1.vn
Pullback Watch: Does Whitehawk Therapeutics Inc have a sustainable dividendWeekly Stock Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PR Newswire
Whitehawk Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aug Patterns: How does Whitehawk Therapeutics Inc score in quality rankingsMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
Inside Whitehawk's 3 next-gen cancer drug conjugates debuting at AACR 2026 - Stock Titan
Whitehawk Therapeutics Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsWHWK - GuruFocus
Oppenheimer Sticks to Their Buy Rating for Whitehawk Therapeutics (WHWK) - The Globe and Mail
Suvretta Capital Management LLC Buys Shares of 3,700,000 Whitehawk Therapeutics, Inc. $WHWK - MarketBeat
2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC - MarketBeat
Whitehawk Therapeutics (WHWK) Swings To US$0.37 EPS Profit Challenging Bearish Turnaround Skepticism - simplywall.st
Whitehawk Therapeutics Inc (WHWK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):